Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study.

Date publication

septembre 2017

Journal

The journal of vascular access

Auteurs

Membres identifiés du Cancéropôle Est :
Dr RANGEARD Olivier

Tous les auteurs :
Marcy PY, Schiappa R, Ferrero JM, Dahlet C, Brenet O, Yazbec G, Dubois PY, Salm B, Fouche Y, Mari V, Montastruc M, Lebrec N, Ancel B, Paillocher N, Dupoiron D, Rangeard O, Gal J, Ettaiche M, Chateau Y, Chamorey E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28731491

Résumé

Most cancer patients require a totally implanted central venous catheter (TIVAD) for their treatment. In a previous study, we developed and validated a questionnaire dubbed QASICC (Questionnaire for Acceptance of, and Satisfaction with, Implanted Central Venous Catheter) assessing patient satisfaction with, and acceptance of, their TIVAD. In the present study, we conducted a large, prospective, multicenter study in cancer patients aimed to analyze factors that could influence patients' acceptance of, and satisfaction with, their device.

Mots clés

Administration, Intravenous, Adult, Aged, Antineoplastic Agents, administration & dosage, Catheterization, Central Venous, instrumentation, Catheters, Indwelling, Central Venous Catheters, Female, France, Humans, Male, Middle Aged, Neoplasms, diagnosis, Patient Acceptance of Health Care, Patient Satisfaction, Prospective Studies, Psychometrics, Quality of Life, Surveys and Questionnaires, Young Adult

Référence

J Vasc Access. 2017 09 11;18(5):390-395